Healthcare Spending vs. Health Investment: A Growing Divide
A physician examines why insurers rarely invest in chronic illness prevention, citing a structural mismatch between spending and long-term savings.
A fundamental tension runs through the American healthcare system: money flows toward treating illness, not preventing it. That disconnect is the focus of an analysis by Russell Greenfield, MD, who argues that the country pays heavily for healthcare services while systematically underinvesting in actual health outcomes.
At the core of the problem is an incentive misalignment that makes prevention financially unattractive for insurers. A health plan that funds a chronic disease prevention program may never recoup those costs if enrolled members switch to a competing plan before the long-term savings materialize. The result is a structure that rewards reactive treatment over proactive care.
Read more Key Factors to Weigh When Buying a Condo After Downsizing →
The dynamic helps explain why chronic illnesses — which account for the bulk of U.S. healthcare expenditures — remain stubbornly prevalent despite decades of awareness campaigns and policy interventions. When financial incentives discourage the investments most likely to reduce disease burden, systemic change becomes difficult to sustain regardless of medical advances.
Greenfield's examination points to a broader question facing policymakers, employers, and consumers alike: whether the current financing model can ever be realigned to reward long-term wellness over short-term treatment cycles. Without structural changes that keep patients within the same coverage ecosystem long enough to realize prevention savings, the cycle is likely to persist.
Continue reading at All Financial Services & Investing.